Wilms tumor

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 03:15, 25 November 2018 by Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Section editor
Liang.jpg
Wayne H. Liang, MD, MS
Birmingham, AL

LinkedIn
Twitter: WayneLiangMD
3 regimens on this page
3 variants on this page


All lines of therapy

Dactinomycin monotherapy

back to top

Regimen

Study Evidence Comparator Efficacy
Wolff et al. 1968 Randomized (E) Single course of dactinomycin Seems to have superior RFS

Preceding treatment

Chemotherapy

6-week cycle for 3 cycles, then 3-month cycle for 4 cycles

References

  1. Wolff JA, Newton WA Jr, Krivit W, D'Angio GJ. Single versus multiple dose dactinomycin therapy of Wilms's tumor: a controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A). N Engl J Med. 1968 Aug 8;279(6):290-4. link to original article PubMed
    1. Update: Wolff JA, D'Angio G, Hartmann J, Krivit W, Newton WA Jr. Long-term evaluation of single versus multiple courses of actinomycin D therapy of Wilms's tumor. N Engl J Med. 1974 Jan 10;290(2):84-6. link to original article contains verified protocol PubMed